Ophthalmic Drugs Market Analysis by Indication (Dry eye, Glaucoma), By Type (Prescription drugs, over-the-counter drugs), By Dosage Form (liquid ophthalmic drug forms, solid ophthalmic drug forms, semisolid ophthalmic drug forms, multicompartment drug delivery system), By Distribution Channel (hospital pharmacies, drug store, online pharmacies) and by Region: Global Forecast, 2024 - 2034.
- PUBLISHED ON
- 2024-04-20
- NO OF PAGES
- 258
- CATEGORY
- Healthcare & Life Sciences
The Ophthalmic Drugs market is predicted to
develop at a compound annual growth rate (CAGR) of 5.3% from 2024 to 2034, when
it is projected to reach USD 69.04 Billion, based on an average growth pattern.
The market is estimated to reach a value of USD 41.19 Billion in 2024.
SOURCE: We Market Research
Medication
specifically designed to address diseases relating to the eyes is known as an
ophthalmic medicine. They include a range of formulations, including
injectables, ointments, and eye drops. These medications have a variety of
uses, such as treating infections (antibiotics, for example), lowering
inflammation (steroids, for example), controlling glaucoma (lowering
intraocular pressure, for example), managing age-related macular degeneration
(anti-VEGF drugs), and relieving allergy and dry eye symptoms. Mydriatics and
cycloplegics are examples of specialised drugs that relax muscles and dilate
pupils in preparation for surgery or other medical procedures. Ophthalmic
medications are essential for both preserving eye health and efficiently
treating conditions that impair vision and ocular function.
There are
multiple factors driving the global market for ophthalmic medications.
Treatment efficacy is increased by the rising incidence of eye conditions such
as age-related macular degeneration (AMD) and glaucoma, as well as by
developments in drug delivery technology such sustained-release implants. An
ageing population that is more prone to eye conditions increases market demand
even further. The market is growing as a result of technological advancements in
treatments like anti-VEGF medicines for AMD and increased healthcare spending.
Furthermore, early diagnosis and treatment are fueled by proactive screening
programmes and increased awareness of eye health, which highlights the market's
growth trajectory in response to patients' changing needs globally.
Market Scope
|
Report Attributes |
Description |
|
Market Size in 2024 |
USD 41.19 Billion |
|
Market Forecast in 2034 |
USD 69.04 Billion |
|
CAGR % 2024-2034 |
5.3% |
|
Base Year |
2023 |
|
Historic Data |
2016-2022 |
|
Forecast Period |
2024-2034 |
|
Report USP
|
Production, Consumption, company share, company
heatmap, company production capacity, growth factors and more |
|
Segments Covered |
By Indication, By Type, By Dosage Form, By Sales Channel, By
Distribution Channel and By Region |
|
Regional Scope |
North America, Europe, APAC, South America and
Middle East and Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic
Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia;
Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa;
Nigeria |
Ophthalmic Drugs Industry: Dynamics & Restrains
Market opportunity:
We Market
Research: Ophthalmic Drugs Dashboard
Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.
Ophthalmic Drugs Segmentation
Market- By Indication Analysis
By Indication, the Ophthalmic Drugs Market is Categories into Dry eye, Glaucoma. The Glaucoma segment accounts for the largest share of around 78% in 2024.
The driver of the glaucoma segment in the
global ophthalmic drugs market is primarily the increasing prevalence of
glaucoma due to aging populations and rising incidences of chronic diseases
globally, driving demand for effective treatments to manage intraocular pressure
and prevent vision loss.
The
following segments are part of an in-depth analysis of the global Ophthalmic
Drugs market:
|
Market Segments |
|
|
By Type |
·
Prescription drugs ·
Over-the-counter drugs |
|
By Dosage Form |
·
Liquid ophthalmic drug forms ·
Solid ophthalmic drug forms ·
Semisolid ophthalmic drug
forms ·
Multicompartment drug
delivery system |
|
By Distribution Channel |
·
Hospital pharmacies ·
Drug store ·
Online pharmacies |
Ophthalmic Drugs Industry: Regional Analysis
North America Market Forecast
North America dominate the Ophthalmic Drugs
Market with the highest revenue generating market with share of more than 46%. The
Ophthalmic Drugs market dominates the region due to high healthcare
expenditure, advanced healthcare infrastructure, and a significant prevalence
of eye disorders such as glaucoma and age-related macular degeneration (AMD).
The presence of key market players and ongoing research activities further
bolster market growth.
Europe Market Statistics
Europe's Ophthalmic
Drugs market benefits from the rising incidence of eye related problems. Europe
has a strong market presence driven by an aging population and increasing
incidences of eye diseases. Countries like Germany, France, and the UK are
major contributors due to well-established healthcare systems and high
awareness among patients.
Asia Pacific Market Forecasts
Asia Pacific is
expected to be the fastest-growing regional segment of the Ophthalmic Drugs
market during the forecast period. In the Asia Pacific, region is experiencing
rapid growth in the ophthalmic drugs market due to improving healthcare
infrastructure, rising disposable incomes, and a growing elderly population
prone to eye disorders. Countries like China, Japan, and India are key markets,
with increasing investments in healthcare and pharmaceutical sectors.
Key Market Players
The Ophthalmic Drugs Market is dominated by a few
large companies, such as
·
F. Hoffmann-La Roche Ltd
·
Bausch Health Companies Inc.
·
Johnson & Johnson services
·
Novartis AG
·
Santen pharmaceutical company limited
·
Pfizer Inc.
· Others
1.
Global
Ophthalmic Drugs Market Introduction and Market Overview
1.1. Objectives of the Study
1.2. Global Ophthalmic Drugs Market
Scope and Market Estimation
1.2.1.Global Ophthalmic Drugs Overall
Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)
1.2.2.Global Ophthalmic Drugs Market
Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034
1.3. Market Segmentation
1.3.1.Indication of Global Ophthalmic
Drugs Market
1.3.2.Type of Global Ophthalmic Drugs
Market
1.3.3.Dosage Form of Global Ophthalmic
Drugs Market
1.3.4.Dosage Form of Global Ophthalmic
Drugs Market
1.3.5.Region of Global Ophthalmic
Drugs Market
2.
Executive Summary
2.1. Market Dynamics
2.1.1.Drivers
2.1.2.Limitations
2.1.3.Opportunities
2.1.4.Impact Analysis of Drivers and
Restraints
2.2. Pricing Trends Analysis &
Average Selling Prices (ASPs)
2.3. Key Mergers & Acquisitions,
Expansions, JVs, Funding / VCs, etc.
2.4. Porter’s Five Forces Analysis
2.4.1.Bargaining Power of Suppliers
2.4.2.Bargaining Power of Buyers
2.4.3.Threat of Substitutes
2.4.4.Threat of New Entrants
2.4.5.Competitive Rivalry
2.5. Market Investment Opportunity
Analysis (Top Investment Pockets), By Segments & By Region
3.
Global Ophthalmic Drugs Market Estimates & Historical Trend Analysis (2019 -
2023)
4.
Global Ophthalmic Drugs Market Estimates & Forecast Trend Analysis, by
Indication
4.1. Global Ophthalmic Drugs Market
Revenue (US$ Mn) Estimates and Forecasts, by Indication, 2019 to 2034
4.1.1.Dry eye
4.1.2.Glaucoma
5.
Global Ophthalmic Drugs Market Estimates & Forecast Trend Analysis, by
Type
5.1. Global Ophthalmic Drugs Market
Revenue (US$ Mn) Estimates and Forecasts, by Type, 2019 to 2034
5.1.1.Prescription drugs
5.1.2.Over-the-counter drugs
6.
Global Ophthalmic Drugs Market Estimates & Forecast Trend Analysis, by
Dosage Form
6.1. Global Ophthalmic Drugs Market
Revenue (US$ Mn) Estimates and Forecasts, by Dosage Form,
2019 to 2034
6.1.1.Liquid ophthalmic drug forms
6.1.2.Solid ophthalmic drug forms
6.1.3.Semisolid ophthalmic drug forms
6.1.4.Multicompartment drug delivery
system
7.
Global Ophthalmic Drugs Market Estimates & Forecast Trend Analysis, by
Distribution Channel
7.1. Global Ophthalmic Drugs Market
Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel,
2019 to 2034
7.1.1.Hospital pharmacies
7.1.2.Drug store
7.1.3.Online pharmacies
8.
Global Ophthalmic Drugs Market Estimates & Forecast Trend Analysis,
by Region
8.1. Global Ophthalmic Drugs Market
Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034
8.1.1.North America
8.1.2.Europe
8.1.3.Asia Pacific
8.1.4.Middle East & Africa
8.1.5.South America
9.
North
America Ophthalmic Drugs Market: Estimates & Forecast Trend Analysis
9.1.
North
America Ophthalmic Drugs Market Assessments & Key Findings
9.1.1.North America Ophthalmic Drugs
Market Introduction
9.1.2.North America Ophthalmic Drugs
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
9.1.2.1. By Indication
9.1.2.2. By Type
9.1.2.3. By Dosage Form
9.1.2.4. By Distribution
Channel
9.1.2.5. By Country
9.1.2.5.1. The U.S.
9.1.2.5.2. Canada
9.1.2.5.3. Mexico
10. Europe Ophthalmic
Drugs Market: Estimates & Forecast
Trend Analysis
10.1. Europe Ophthalmic Drugs Market
Assessments & Key Findings
10.1.1. Europe Ophthalmic Drugs Market
Introduction
10.1.2. Europe Ophthalmic Drugs Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
10.1.2.1. By Indication
10.1.2.2. By Type
10.1.2.3. By Dosage Form
10.1.2.4. By Distribution
Channel
10.1.2.5. By Country
10.1.2.5.1. Germany
10.1.2.5.2. U.K.
10.1.2.5.3. France
10.1.2.5.4. Italy
10.1.2.5.5. Spain
10.1.2.5.6. Russia
10.1.2.5.7. Rest of Europe
11. Asia Pacific Ophthalmic
Drugs Market: Estimates & Forecast
Trend Analysis
11.1. Asia Pacific Market Assessments
& Key Findings
11.1.1. Asia Pacific Ophthalmic Drugs
Market Introduction
11.1.2. Asia Pacific Ophthalmic Drugs
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
11.1.2.1. By Indication
11.1.2.2. By Type
11.1.2.3. By Dosage Form
11.1.2.4. By Distribution
Channel
11.1.2.5. By Country
11.1.2.5.1. China
11.1.2.5.2. Japan
11.1.2.5.3. India
11.1.2.5.4. Australia
11.1.2.5.5. South Korea
11.1.2.5.6. ASEAN
11.1.2.5.7. Rest of Asia Pacific
12. Middle East & Africa Ophthalmic
Drugs Market: Estimates & Forecast
Trend Analysis
12.1. Middle East & Africa Market
Assessments & Key Findings
12.1.1. Middle
East & Africa Ophthalmic
Drugs Market Introduction
12.1.2. Middle
East & Africa Ophthalmic
Drugs Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
12.1.2.1. By Indication
12.1.2.2. By Type
12.1.2.3. By Dosage Form
12.1.2.4. By Distribution
Channel
12.1.2.5. By Country
12.1.2.5.1. U.A.E.
12.1.2.5.2. Saudi Arabia
12.1.2.5.3. Egypt
12.1.2.5.4. South Africa
12.1.2.5.5. Rest of Middle East & Africa
13. South America
Ophthalmic Drugs Market: Estimates
& Forecast Trend Analysis
13.1. South America Market Assessments
& Key Findings
13.1.1. South America Ophthalmic Drugs
Market Introduction
13.1.2. South America Ophthalmic Drugs
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
13.1.2.1. By Indication
13.1.2.2. By Type
13.1.2.3. By Dosage Form
13.1.2.4. By Distribution
Channel
13.1.2.5. By Country
13.1.2.5.1. Brazil
13.1.2.5.2. Argentina
13.1.2.5.3. Colombia
13.1.2.5.4. Rest of South America
14. Competition Landscape
14.1. Global Ophthalmic Drugs Market
Competition Matrix & Benchmarking, by Leading Players / Innovators /
Emerging Players / New Entrants
14.2. Global Ophthalmic Drugs Market
Competition White Space Analysis, By End-user
14.3. Global Ophthalmic Drugs Market
Competition Heat Map Analysis, By End-user
14.4. Global Ophthalmic Drugs Market
Concentration & Company Market Shares (%) Analysis, 2022
15. Company Profiles
15.1.
F. Hoffmann-La Roche AG.
15.1.1. Company Overview & Key Stats
15.1.2. Financial Performance & KPIs
15.1.3. Product Portfolio
15.1.4. Business Strategy & Recent
Developments
* Similar details would be provided
for all the players mentioned below
15.2. Bausch Health
Companies Inc.
15.3. Johnson & Johnson
services
15.4. Novartis AG
15.5. Santen
pharmaceutical company limited
15.6. Pfizer Inc.
15.7. Others
16. Research
Methodology
16.1. External Transportations /
Databases
16.2. Internal Proprietary Database
16.3. Primary Research
16.4. Secondary Research
16.5. Assumptions
16.6. Limitations
16.7. Report FAQs
17. Research
Findings & Conclusion
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Frequently Asked Questions
What is the market size of Ophthalmic Drugs Market in 2024?
Ophthalmic Drugs Market was valued at USD 41.19 Billion in 2024.
What is the growth rate for the Ophthalmic Drugs Market?
Ophthalmic Drugs Market size will increase at approximate CAGR of 5.3% during the forecasted period.
Which are the top companies operating within the market?
Major companies operating within the Ophthalmic Drugs Market Are F. Hoffmann-La Roche Ltd, Bausch Health Companies Inc., Johnson & Johnson services, Novartis AG, Santen pharmaceutical company limited, Pfizer Inc. and Others.
Which region dominates the Ophthalmic Drugs Market?
North America dominates the market with an active share of 46%.
}})
Select a license type that suits your business needs
US $3499
Only Three Thousand Four Hundred Ninety Nine US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4499
Only Four Thousand Four Hundred Ninety Nine US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5499
Only Five Thousand Four Hundred Ninety Nine US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI